Concepedia

D.S. Keller

DK

Statistics

Publications

16

Citations

1.3K

H-Index

14

Active since

1986

Affiliations

Pfizer (United States)(Current)

Yale University

Pfizer (United Kingdom)

University of Guelph

Nordic Bioscience (Denmark)

D.S. Keller is an author at Pfizer (United States) specializing in intracellular transport, endoplasmic reticulum-to-golgi transport, and protein transport through the golgi.

Publications per year

1986–2018

16

Publications

16

Semi-intact cells permeable to macromolecules: Use in reconstitution of protein transport from the endoplasmic reticulum to the Golgi complex

C J Beckers, D.S. Keller, William E. Balch · Cell · 1987 · 322 citations

, , +17

Role for adenosine triphosphate in regulating the assembly and transport of vesicular stomatitis virus G protein trimers.

Robert W. Doms, D.S. Keller, Ari Helenius et al. · The Journal of Cell Biology · 1987 · 285 citations · Full text

, , +17

Efficacy and safety of tanezumab versus naproxen in the treatment of chronic low back pain

Alan Kivitz, Joseph Gimbel, Candace Bramson et al. · Pain · 2013 · 143 citations

, , +16

ATP-coupled transport of vesicular stomatitis virus G protein between the endoplasmic reticulum and the Golgi.

William E. Balch, Margaret Elliott, D.S. Keller · Journal of Biological Chemistry · 1986 · 140 citations · Full text

, , +17

Efficacy and Safety of Intravenous Tanezumab for the Symptomatic Treatment of Osteoarthritis: 2 Randomized Controlled Trials versus Naproxen

Evan F. Ekman, Joseph Gimbel, Alfonso E. Bello et al. · The Journal of Rheumatology · 2014 · 86 citations · Full text

, , +16

1–5 of 16